Effects of extracellular acetylcholine on muscarinic receptor binding assessed by [125I]dexetimide and a simple probe

European Journal of Pharmacology

Volumn 358, Issue 3, 1998, Pages 207-211

  Sánchez Roa, Patricia M ^a   Wagner Jr , Henry N ^a   Villemagne, Victor L ^b   London, Edythe D ^b   Lever, John R ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acetylcholine; Brain; Dexetimide; Muscarinic receptor; Physostigmine; Radiation detection system

Indexed keywords

ACETYLCHOLINE; DEXETIMIDE; IODINE 125; MUSCARINIC RECEPTOR; PHYSOSTIGMINE; TRACER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN; CHOLINERGIC ACTIVITY; CONTROLLED STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION DETECTION; RECEPTOR BINDING;

ACETYLCHOLINE; ANIMALS; BRAIN; DEXETIMIDE; EXTRACELLULAR SPACE; GAMMA CAMERAS; IODINE RADIOISOTOPES; MALE; MICE; MUSCARINIC ANTAGONISTS; PHYSOSTIGMINE; RECEPTORS, MUSCARINIC;

EID: 0345214525     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00633-5     Document Type: Article

References (32)

1. Bertrand, N., Beley, A., 1990. Effect of oxitremorine, physostigmine, and scopolamine on brain acetylcholine synthesis: a study using HPLC. Neurochem. Res. 15, 1097-1100.
2. Björklund, A., Dunnett, S., 1995. Acetylcholine revisited. Nature 375, 446.
3. Buccafusco, J.J., Jackson, W.J., Terry Jr., A.V., Marsh, K.C., Decker, M.W., Arneric, S.P., 1995. Improvement in performance of a delayed matching-to-sample task by monkeys following ABT-418: a novel cholinergic channel activator for memory enhancement. Psychopharmacology 120, 256-266.
4. Claus, J.J., Dubois, E.A., Booij, J., Habraken, J., de Munk, J.C., Van Herk, M., Verbeeten Jr., B., Van Royen, A., 1997. Demonstration of a reduction in muscarinic receptor binding in early Alzheimer's disease using iodine-123 dexetimide single-photon emission tomogra-phy. Eur. J. Nucl. Med. 24, 602-608.
5. Collerton, D., 1986. Cholinergic function and intellectual decline in Alzheimer's disease. Neuroscience 19, 1-18.
6. Cook, L., Nickolson, V.J., Steinfels, G.F., Rohrbach, K.W., DeNoble, V.J., 1990. Cognition enhancement by the acetylcholine releaser DuP 996. Drug Dev. Res. 19, 301-314.
7. Dawson, G.R., Iversen, S.D., 1993. The effects of novel cholinesterase inhibitors and selective muscarinic receptor agonists in tests of reference and working memory. Behav. Brain Res. 57, 143-153.
8. Hallak, M., Giacobini, E., 1986. Relation of physostigmine concentration to regional cholinesterase activity and acetylcholine and choline levels in rat brain. Neurochem. Res. 11, 1037-1048.
9. Jerusalinsky, D., Kornisiuk, E., Izquierdo, I., 1997. Cholinergic neurotransmission and synaptic plasticity concerning memory processing. Neurochem. Res. 22, 507-515.
10. Kim, S., Wagner Jr., H.N., Villemagne, V.L., Kao, P.F., Dannals, R.F., Ravert, H.T., Reynolds, R.D., Joh, T., Dixon, R.B., Civelek, A.C., 1997. Longer occupancy of opioid receptors by nalmefene compared to naloxone. J. Nucl. Med. 38, 1726-1731.
11. 3H]-dexetimide to brain muscarinic receptors. J. Neurochem. 32, 421-427.
12. Lee, M.C., Wagner Jr., H.N., Tanada, S., Frost, J.J., Bice, A.N., Dannals, R. F., 1988. Duration of occupancy of opiate receptors by naltrexone. J. Nucl. Med. 29, 1207-1211.
13. Liu, X., Musachio, J.L., Wagner Jr., H.N., Mochizuki, T., Dannals, R.F., London, E.D., 1997. External monitoring of cerebral nicotinic acetyl-choline receptors in living mice. Synapse 27, 378-380.
14. Matsumura, K., Uno, Y., Scheffel, U., Wilson, A.A., Dannals, R.F., Wagner Jr., H.N., 1991. In vivo and in vitro characterization of 4-[125]iododexetimide binding to muscarinic cholinergic receptors in the rat heart. J. Nucl. Med. 32, 76-80.
15. Messamore, E., Ogane, N., Giacobini, E., 1993a. Cholinesterase inhibitor effects on extracellular acetylcholine in rat striatum. Neuropharmacology 32, 291-296.
16. Messamore, E., Warpman, U., Ogane, N., Giacobini, E., 1993b. Cholinesterase inhibitor effects on extracellular acetylcholine in rat cortex. Neuropharmacology 32, 745-750.
17. 125 I]RTI-55 in mouse brain in vivo. Eur. J. Pharmacol. 338, 17-23.
18. Moor, E., Schirm, E., Jacso, J., Westerink, B.H.C., 1998. Effects of neostigmine and atropine on basal and handling-induced acetylcholine output from ventral hippocampus. Neuroscience 82, 819-825.
19. 123I]-4-iodolevetimide. J. Cereb. Blood Flow Metab. 12, 562-570.
20. 123I-iododexetimide and single-photon emission computed tomography in epilepsy. Ann. Neurol. 34, 235-238.
21. Palacios, J.M., Mengod, G., Vilaro, M.T., Wiederhold, K.H., Boddeke, H., Alvarez, F.J., Chinaglia, G., Probst, A., 1990. Cholinergic receptors in the rat and human brain: microscopic visualization. In: Aquilonious, S.M., Gillberg, P.G. (Eds.), Progress in Brain Research. Elsevier, Cambridge, pp. 243-253.
22. Pereira, E.F., Alkondon, M., Tano, T., Castro, N.G., Froes-Ferrao, M.M., Rozental, R., Aronstam, R.S., Schrattenholz, A., Maelicke, A., Albuquerque, E.X., 1993. A novel agonist binding site on nicotinic acetylcholine receptors. J. Recept. Res. 13, 413-436.
23. 125I]-4-iodolevetimide. Neuropharmacology 32, 1441-1443.
24. Schorderet, M., 1995. Alzheimer's disease: fundamental and therapeutic aspects. Experientia 51, 99-105.
25. Somani, S.M., Khalique, A., 1987. Pharmacokinetics of physostigmine in the rat after intravenous administration. Drug Metab. Dispos. 15, 627-633.
26. Somani, S.M., Gupta, S.K., Khalique, A., Unni, L.K., 1991. Physiological pharmacokinetic and pharmacodynamic model of physostigmine in the rat. Drug Metab. Dispos. 19, 655-660.
27. Tariot, P.N., Cohen, R.M., Welkowitz, J.A., Sunderland, T., Newhouse, P.A., Murphy, D.L., Weingarten, H., 1988. Multiple-dose arecoline infusions in Alzheimer's disease. Arch. Gen. Psychiatry 45, 901-905.
28. Taylor, P., 1990. Anticholinesterase agents. In: Goodman Gilman, A., Rail, T.W., Nies, A.S., Taylor, P. (Eds.), The Pharmacological Basis of Therapeutics. Pergamon, New York, NY, pp. 131-149.
29. Tsai, T.R., Cham, T.M., Chen, K.C., Chen, C.F., Tsai, T.H., 1996. Determination of acetylcholine by on line microdialysis coupled with pre- and post-microbore column enzyme reactors with electrochemical detection. J. Chromatogr. B Biomed. Appl. 678, 151-155.
30. 123I]-4-iododexetimide, a potent muscarinic cholinergic receptor antagonist. J. Med. Chem. 32, 1057-1062.
31. Winkler, J., Suhr, S.T., Gage, F.H., Thai, L.J., Fisher, L.J., 1995. Essential role of neocortical acetylcholine in spatial memory. Nature 375, 484-487.
32. Xiao, W.B., Nordberg, A., Zhang, X., 1993. Effect of in vivo microdialy-sis of 1,2,3,4-tetrahydro-9-aminoacridine (THA) on the extracellular concentration of acetylcholine in the striatum of anesthetized rats. J. Pharmacol. Exp. Ther. 265, 759-764.